FDA approves the drug, ‘BiNig” (Pronounced “Bye-Nig”–at least that is what I am calling it!)
on June 24th, 2005 at 7:43 am“The Food and Drug Administration on Thursday approved a drug, ‘BiDil’ for the treatment of heart failure in African Americans.
According to The Associated Press report, the FDA defended their stance by calling it a step toward “the promise of personalized medicine.”
Yet, the FDA approval has triggered a racial debate.
Questions have already been raised on the validity of medical research that is primarily based on race.
According to the Associated Press David Magnus, director of the Stanford Medical Center for Biomedical Ethics, says, “There are many who claim these use of [racial] categories may not have any biological meaning, only social meaning, and basing medical decisions on them may be problematic.”
However, research indicated that ‘BiDil’ had a positive effect on a population excessively burdened by cardiovascular disease.
“African-Americans between the ages of 45 and 64 are 2.5 times more likely to die prematurely from heart failure than their non-black counterparts,” Dr. Anne Taylor of the University of Minnesota Medical School told The Associated Press. “FDA approval of BiDil represents an important leap forward in addressing this health disparity.” (more…)”
===========
Nope! No way! No thanks!
I think we all know that there has been way too many “medical” experiments performed on black folks. Why are we the first group of people being tested for racially-developed medicine? I can somewhat understand their reasoning that blacks lead the stats in cardiovascular disease. However, whites are 10 times more likely to develop skin cancer and more likely to develop breast cancer. Where is the “white” medicine for them?
And let’s not even talk about potential side effects (you know, that long list that is read on pharmaceutical commercials while the actors are playing at the beach).
History is screaming at us on this one, y’all.
